Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

NCT01140867 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: zonisamide

Sponsor

Eisai Korea Inc.